Malaria vaccines - Bharat Biotechnologies

Drug Profile

Malaria vaccines - Bharat Biotechnologies

Alternative Names: Malaria Vaccine 1; Malaria Vaccine 2; Malaria Vaccine 3; Malaria Vaccine 4

Latest Information Update: 19 Mar 2009

Price : $50

At a glance

  • Originator Bharat Biotech
  • Class Antimalarials; Parasitic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Clinical Phase Unknown Malaria
  • Discontinued Encephalitis virus infections

Most Recent Events

  • 19 Mar 2009 Clinical trials in Malaria in India (unspecified route)
  • 19 Mar 2007 Discontinued - Preclinical for Encephalitis virus infections in India (unspecified route)
  • 19 Mar 2007 Preclinical development is ongoing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top